CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Herantis Pharma Oyj Company Snapshot
Herantis Pharma Oyj operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Herantis Pharma Oyj with three other miscellaneous service companies in Europe: Reneuron Group PLC of the United Kingdom (2016 sales of £29,000.00 [US$38,359.75 ] of which 100% was Cell-Based Therapies), Nordic Nanovector Asa of Norway (314,000.00 Norwegian Kroner [US$37,862.12 ] ), and Immunovia AB (publ) which is based in Sweden (177,284.00 Swedish Kronor [US$20,896.47 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Herantis Pharma Oyj
  Stock Performance Chart for Herantis Pharma Oyj
 
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 5.80
(Figures in Euro)
1 Week -5.7%   13 Weeks -10.8%  
4 Weeks -27.5%   52 Weeks 300.0%  
 
Herantis Pharma Oyj Key Data:
  Ticker: HRTIS Country: Finland
  Exchanges: HEL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 25,292
(Year Ending Jan 2017).
Employees: N/A
  Currency: Euro Market Cap: 23,886,169
  Fiscal Yr Ends: December Shares Outstanding: 4,118,305
  Share Type: Ordinary Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.